Current best practice in pulmonary rehabilitation for chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease
Francesco De Blasio, Mario Polverino

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic condition that negatively affects several patient-centered outcomes. Among these, exercise capacity, dyspnea, and quality of life are the most relevant. In this article, factors contributing to exercise limitation, increase in exercise-induced dyspnea, quality of life deterioration, and other pathophysiological aspects in patients with COPD are analyzed in detail. Pulmonary rehabilitation (PR) is an evidence-based, multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. PR has been clearly shown to induce favorable and long-lasting effects on all patient-centered outcomes. In addition, PR appears to have positive (even if not conclusively demonstrated) effects on other important outcomes in patients with COPD: number and severity of exacerbations, healthcare resource utilization, and survival. The organization of PR treatment, its components, outcome assessment, and future directions are discussed in light of the most robust scientific evidence.

References

Mar 1, 1991·The American Review of Respiratory Disease·F J MartinezB R Celli
Jul 1, 1985·The International Journal of Neuroscience·A J FixC J Golden
Aug 1, 1982·Archives of Internal Medicine·I GrantR M Timms
Jul 1, 1995·American Journal of Respiratory and Critical Care Medicine·S K EpsteinT Shannon
Nov 1, 1994·American Journal of Respiratory and Critical Care Medicine·M Di FranciaJ Orehek
Mar 1, 1996·American Journal of Respiratory and Critical Care Medicine·R GosselinkM Decramer
Nov 1, 1996·Archives of Physical Medicine and Rehabilitation·J VottoR ZuWallack
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·A M ScholsE F Wouters
Oct 9, 2001·The European Respiratory Journal·P M MeekD Anderson
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·M B Reid
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·R DebigaréF Maltais
Jul 2, 2002·American Journal of Respiratory and Critical Care Medicine·UNKNOWN ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
Aug 21, 2002·American Journal of Respiratory and Critical Care Medicine·Alvar G N AgustíXavier Busquets
Oct 9, 2002·Medicine and Science in Sports and Exercise·Frits M E FranssenAnnemie M W J Schols
Feb 26, 2003·Revue des maladies respiratoires·A CuvelierF Chabot
Mar 1, 2003·The European Respiratory Journal·A G N AgustíX Busquets
Mar 8, 2003·Archives of Internal Medicine·Jean BourbeauUNKNOWN Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec
Feb 6, 2004·Journal of Cardiopulmonary Rehabilitation·UNKNOWN California Pulmonary Rehabilitation Collaborative Group
Mar 5, 2004·The New England Journal of Medicine·Bartolome R CelliHoward J Cabral
May 1, 2004·Medicina clínica·Juana M Martínez-LlorensJoaquim Gea
Jun 29, 2004·The European Respiratory Journal·D E O'DonnellH Magnussen
Aug 11, 2004·Molecular Aspects of Medicine·Michael R Duchen
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Fabio PittaRik Gosselink
Mar 22, 2005·American Journal of Respiratory and Critical Care Medicine·Thierry TroostersMarc Decramer
Apr 26, 2005·American Journal of Respiratory and Critical Care Medicine·Coen A C OttenheijmP N Richard Dekhuijzen
Aug 23, 2005·Proceedings of the American Thoracic Society·Robert Naeije

❮ Previous
Next ❯

Citations

Dec 26, 2013·International Journal of Chronic Obstructive Pulmonary Disease·Jean-Louis CorhayRenaud Louis
May 23, 2013·Respirology : Official Journal of the Asian Pacific Society of Respirology·Eulogio PleguezuelosMarc Miravitlles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.